Targeted Treatments for Tots
New law mandates that cancer drugs get tested in kids in clinical trials.
Progress Against Cancer
New law mandates that cancer drugs get tested in kids in clinical trials.
Researchers are studying how best to support cancer caregivers.
Research indicates that only a small percentage of high-risk individuals eligible for lung cancer screening actually undergo a scan.
A new study explores the impact of lowering a patient's dose due to side effects.
Jocelyn Tan, MD, answers questions on research into whether the keto diet may have a role in cancer treatment.
Experts at the San Antonio Breast Cancer Symposium discussed avenues for further development following the approval of the first immunotherapy for breast cancer by the U.S. Food and Drug Administration in March 2019.
Studies presented at the San Antonio Breast Cancer Symposium show additional treatment options.
Compared with intravenous paclitaxel, the oral form of the chemotherapy drug has been associated with improved tumor shrinkage in metastatic breast cancer patients.
While most primary cancer diagnoses have no standard of care for brain metastasis screening, a study published in Cancer Epidemiology, Biomarkers, & Prevention, a journal of the American Association for Cancer Research (AACR), found that elderly survivors of lung cancer, breast cancer, and melanoma face a persistent risk of brain metastasis.
Two studies in the AACR journal Clinical Cancer Research report that a liquid biopsy test would provide clinicians with a noninvasive way to routinely scan for biomarkers for response to immunotherapy and potentially reach more patients eligible for treatment with these therapeutics.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More